These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 30349193

  • 1. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT, Yang L, Xu FQ, Dong FW, Yang D, Li Y, Ding ZT, Zhou J, Jiang ZH, Hu JM.
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.
    Zi CT, Liu ZH, Li GT, Li Y, Zhou J, Ding ZT, Hu JM, Jiang ZH.
    Molecules; 2015 Feb 16; 20(2):3255-80. PubMed ID: 25690288
    [Abstract] [Full Text] [Related]

  • 3. Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity.
    Zi CT, Yang L, Kong QH, Li HM, Yang XZ, Ding ZT, Jiang ZH, Hu JM, Zhou J.
    Drug Des Devel Ther; 2019 Feb 16; 13():3683-3692. PubMed ID: 31695335
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and anticancer activity of glucosylated podophyllotoxin derivatives linked via 4β-triazole rings.
    Zi CT, Xu FQ, Li GT, Li Y, Ding ZT, Zhou J, Jiang ZH, Hu JM.
    Molecules; 2013 Nov 13; 18(11):13992-4012. PubMed ID: 24232736
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
    Liu J, Cao B, Gao Y, Bai M, Mei X, Chen H, Jiang YG, Huang DJ.
    J Asian Nat Prod Res; 2013 Sep 13; 15(9):985-92. PubMed ID: 23859462
    [Abstract] [Full Text] [Related]

  • 6. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR, Searcy JD, Tan R, Cragg GM, Melody N, Knight JC, Chapuis JC.
    J Nat Prod; 2016 Mar 25; 79(3):507-18. PubMed ID: 26938998
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L, Liu YQ, Tan H, Li WG, Tian X.
    Nat Prod Res; 2007 Sep 25; 21(11):998-1008. PubMed ID: 17691049
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H, Chen H, Zhao D, Tang X, Liu Y, Pan L, Cheng M.
    Arch Pharm (Weinheim); 2012 Jan 25; 345(1):43-8. PubMed ID: 21956645
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives.
    Zi CT, Yang D, Dong FW, Li GT, Li Y, Ding ZT, Zhou J, Jiang ZH, Hu JM.
    Bioorg Med Chem; 2015 Apr 01; 23(7):1437-46. PubMed ID: 25744190
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
    Guo YE, Chen H, Zuo S, Liu DL, Lu YL, Lv JJ, Wen SP, Zhang TC.
    J Asian Nat Prod Res; 2011 May 01; 13(5):417-24. PubMed ID: 21534039
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB, Paul DV, Agrawal SK, Saxena AK, Kumar HM, Qazi GN.
    Arch Pharm (Weinheim); 2008 Feb 01; 341(2):126-31. PubMed ID: 18214838
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives.
    Yu PF, Chen H, Wang J, He CX, Cao B, Li M, Yang N, Lei ZY, Cheng MS.
    Chem Pharm Bull (Tokyo); 2008 Jun 01; 56(6):831-4. PubMed ID: 18520089
    [Abstract] [Full Text] [Related]

  • 13. SAR analysis and biological studies of synthesized podophyllum derivates obtained by N linkage modification at C-4 position.
    Wang H, Tang L, Tang Y, Yuan Z.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6183-92. PubMed ID: 25282651
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR, Xu B, Yang YQ, Zhang XY, Fang K, Ma T, Wang H, Xue NN, Chen M, Guo WB, Jia XH, Wang PL, Lei HM.
    Eur J Med Chem; 2018 Jul 15; 155():183-196. PubMed ID: 29886322
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
    Liu JF, Sang CY, Xu XH, Zhang LL, Yang X, Hui L, Zhang JB, Chen SW.
    Eur J Med Chem; 2013 Jun 15; 64():621-8. PubMed ID: 23711769
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antitumor activity of camptothecin- 4β-triazolopodophyllotoxin conjugates.
    Zi CT, Yang L, Dong FW, Kong QH, Ding ZT, Zhou J, Jiang ZH, Hu JM.
    Nat Prod Res; 2020 Aug 15; 34(16):2301-2309. PubMed ID: 30636439
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and Anticancer Activity of 4β-Triazole-podophyllotoxin Glycosides.
    Zi CT, Li GT, Li Y, Zhou J, Ding ZT, Jiang ZH, Hu JM.
    Nat Prod Bioprospect; 2015 Apr 14; 5(2):83-90. PubMed ID: 25869591
    [Abstract] [Full Text] [Related]

  • 18. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
    Zilla MK, Nayak D, Vishwakarma RA, Sharma PR, Goswami A, Ali A.
    Eur J Med Chem; 2014 Apr 22; 77():47-55. PubMed ID: 24607588
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.
    Zhao Y, Wang C, Wu Z, Fang J, Zhu L.
    Invest New Drugs; 2012 Feb 22; 30(1):17-24. PubMed ID: 20697773
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of 4beta-amido and 4beta-sulphonamido analogues of podophyllotoxin as potential antitumour agents.
    Kamal A, Ashwini Kumar B, Arifuddin M, Dastidar SG.
    Bioorg Med Chem; 2003 Nov 17; 11(23):5135-42. PubMed ID: 14604676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.